NUR 3050 Final Exam Questions with
Complete Answers
assessment - Answer-first part of the nursing process that involves collecting,
organizing, validating, and documenting data starting with the initial contact with the
patient, continuing with every interaction after
-This includes gathering baseline data, subjective data, objective data, and a health
history
diagnosis - Answer-second part of the nursing process involving judgement by the
nurse of the patient's actual or potential health problem after assessing the data
collected
-includes analyzing data, identifying health problems, risks, and strengths, and
formulating diagnostic statements
-goal is to provide the basis for the plan and remaining steps
planning - Answer-third step of the nursing process where the nurse reviews the
diagnosis, establishes goals and outcomes, and sets nursing interventions that would
best help the patient and established diagnosis
-includes prioritizing problems/diagnoses, formulating goals/desired outcomes, selecting
nursing interventions, and writing nursing interventions
-goal is to establish a well-thought plan before taking action
Intervention (Implementation) - Answer-fourth step of the nursing process where the
nurse uses all information gathered as well as the established plan and puts them into
action to reach the established goals and outcomes
-includes reassessing the client, determining the nurses need for assistance,
implementing the nursing interventions, supervising delegated care, and documenting
nursing activities
evaluation - Answer-last step of nursing process where once the plan has been put into
action, the nurse must now assess the outcomes and if the patient's health status has
improved
-includes collecting data related to outcomes, comparing data with outcomes, relate
nursing actions to client goals/outcomes, drawing conclusion about problem status, and
continuing, modifying, or terminating the patient's care plan
adverse effect - Answer-unintended, unfavorable, and often unpredictable drug reaction
-warrant either lowing the dosage of the drug or discontinuing the drug
indication - Answer-a sign or piece of information that indicates the use of a particular
medication
, contraindication - Answer-any conditions or special circumstances, such as diseases or
conditions, in which use of the drug is undesirable or for which the drug should be given
with caution
Peak drug level - Answer-plasma level when the medication has reached its highest
concentration in the bloodstream
-drawn after drug is administered
trough drug level - Answer-the lowest plasma concentration of a drug, and it measures
the rate at which the drug is eliminated
-drawn between the first and second dose of the drug
Pharmacokinetic phase - Answer-the process of drug movement to achieve drug action
-absorption: process involving the movement of a substance from its site of
administration, across body membranes, to circulating fluids; determines the length of
time it takes a drug to produces its effect
-distribution: involves the transport of drugs throughout the body determined by the
amount of blood flow to body tissues
-metabolism: process of chemically converting a drug to a form that is usually more
easily removed from the body involving complex biochemical pathways and reactions
that alter drugs, nutrients, vitamins, and minerals; primary site is the liver
-excretion: the process by which drugs are removed from the body; primary site is the
kidneys; the rate at which medications are excreted is a primary determinant of the
concentration of the drugs in the bloodstream and tissues
SSRI mechanism of action (selective serotonin reuptake inhibitors) - Answer-selectively
inhibit the reuptake of serotonin with little or no effects on other neurotransmitters in the
CNS such as norepinephrine and dopamine
-slow the reuptake of serotonin into presynaptic nerve terminals, increasing levels of
serotonin in the brain, producing excitatory reactions in the CNS
-too much can lead to serotonin syndrome (panic disorder characterized by mental
status change, hypertension, tremors, sweating hyperpyrexia, ataxia)
MAOI mechanism of action (monoamine oxidase inhibitors) - Answer-inhibit the MAO
enzyme activity inside presynaptic nerve terminals, degrading norepinephrine and other
neurotransmitters, enhancing catecholamine release
-no tyramine diet
lithium - Answer--T: antimanics
-P: alkali metals
-indications: acute mania in bipolar disorder, bipolar disorder
-mechanism of action: alters chemical transmitters in the CNS possibly by interfering
with ionic pump mechanisms in brain cells, and may compete with or replace sodium
ions
-adverse reactions: coma, seizures, hypertension, arrhythmias, bradycardia, renal
toxicity